Worst - Sorin - Too small to be effective in the US. No coverage and support.
Bad to Average - Biotronik and BSX. For the very obvious reasons. Support for Bio and BSX it's product reliability. For both it is leadership.
Above Average - STJ and MDT. STJ products right now are superior with the pipeline churning out more. MDT has given up on CRM R&D once they get the MRI pacer out. Which isn't even groundbreaking with the Conditions set. MDT is used in many places just because they are MDT. Legacy is keeping them going, but they are losing share every day.
Worst - Sorin - Too small to be effective in the US. No coverage and support.
Bad to Average - Biotronik and BSX. For the very obvious reasons. Support for Bio and BSX it's product reliability. For both it is leadership.
Above Average - STJ and MDT. STJ products right now are superior with the pipeline churning out more. MDT has given up on CRM R&D once they get the MRI pacer out. Which isn't even groundbreaking with the Conditions set. MDT is used in many places just because they are MDT. Legacy is keeping them going, but they are losing share every day.
Sorin could have 5000 people in US and they would still be the worst. The products are so bad it's comical and the programmer looks like something from a pawn shop. Any doctor implanting Sorin in their patients is getting paid, nothing else can explain it.
In view of recent Minnesota Judge placing BSX on three year probation and directing to pay $296 million for hiding faults, please rank all CRM companies worst to good in that order.
I am sure BSX ranks first in the list!
so to rank
Sorin (they are climbing, believe it or not, i know 2009 went down but mark my words)
Boston Scientific (declining)
Biotronik (climbing)
Medtronic (they are sliding)
St. Jude (it's good to be king)
I would have to agree with the above poster. I don't feel that medtronic's heart is in CRM anymore and they are just riding past success and name brand.
Sorin would be the "worst" but only because of small market share. If you actually look at their technology, they have some pretty damn good stuff; they just have a marketing problem and lack of personell to push it.
Biotronik has great stuff too, they have the lowest incidence of inappropriate shocks, but again, customer service is lacking due to personell issues.
Boston is a cluster fuck. Goddamn headers falling off the Teligen, getting ripped off the market and a recall on the horizon. Ray isn't getting shit done to change the brand.
St. Jude - nuff said they got their act together, their corporate managing is just a pile of shit and they treat their subordinates like ass clowns.
so to rank
Sorin (they are climbing, believe it or not, i know 2009 went down but mark my words)
Boston Scientific (declining)
Biotronik (climbing)
Medtronic (they are sliding)
St. Jude (it's good to be king)
Actually the data show Sorin-ELA offered the least # of inapproriate shocks 1/100 followed by Bio 1/26.
Let me guess...docs on payola implanting normal ef pts. No mystery there.
Nope, although that happens. It has more to do with the fact that the Sorin's devices don't sense VT/VF, much less SVT or fib. Their devices should be used only in a veterniary setting.
Actually the data show Sorin-ELA offered the least # of inapproriate shocks 1/100 followed by Bio 1/26.
Nope, although that happens. It has more to do with the fact that the Sorin's devices don't sense VT/VF, much less SVT or fib. Their devices should be used only in a veterniary setting.
this is completely wrong, where did you get these facts? I've studies their algorithm's when they approached me for a position (I ultimately did not take it). Their WARAD algorithm trumps PVARP anyday. Their SafeR is pretty cool too, it has a different algorithm for all types of heart block. So to say that they don't dectect VT/VF or SVT and Fib (WARAD destroys Fib) blows my mind.
Maybe i'm wrong here, but please shoot me some facts because what i understand they have really good technology, they just suck at marketing
Puhlease... WARAD is just an rate-dependent TARP - other companies have the same thing in a feature that actually means something to a clinician - they call it Automatic PVARP. And SafeR is better than any AV algorithm out there, but like many ELA features, is overly complicated, switches back to DDD way too often, ends up locked in DDD mode in patients who have intact conduction, yet allows multiple blocked beat and huge pauses when it needs to pace the most. Combine that with an inconceivable lack of remote monitoring in 2011, and you've got a 5th-rate company in a 5 person race.
WARAD - now that's funny!
But your definately missing something on WARAD.
I would submit to you that they're making more out of it then is really there, rather than me missing something. It's rate-dependent TARP, prevents tracking during sudden onset AT/AF, but that's about it.
